Autism Spectrum Disorder Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- The child must be between 2 years old and 5 years and 11 months old at the time of signing up
- The child must have a diagnosis of Autism Spectrum Disorder (ASD), confirmed through medical records or a parent questionnaire
- The child must have a significant delay in language development, based on scores from a specific communication assessment (confirm with trial site for exact score requirements)
- A parent or main caregiver who speaks Spanish must be available to regularly take part in study activities and practice the therapy techniques in Spanish
- If the child is taking any psychiatric medications or receiving other medical treatments, these must have been stable for at least 1 month before the study starts, with no planned changes during the study
- The child's therapy services (such as behavior therapy or speech therapy) and school placement must have been stable for at least 1 month before the study starts, with no expected changes
- The child must be receiving no more than 60 minutes of one-on-one speech therapy per week
Who may not be able to join:
- The child's or parent's primary language is not Spanish
- Either the child or the parent has a serious psychiatric condition or an unstable health condition
- The parent has already learned and practiced the specific therapy used in this study (called Pivotal Response Treatment) to a high level of skill before the study begins
- The child is currently receiving more than 15 hours per week of one-on-one Applied Behavior Analysis (ABA) therapy
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Grace Gengoux, Ph.D., Stanford University
Phone: 6507235511
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in Parent Fidelity of PRT Implementation from Baseline to Week 12
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.